Varbanova, V. P., Mihailova, S., Naumova, E., & Mihaylova, A. P. (2019). Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study. Turk J Haematol.
Citação norma ChicagoVarbanova, Viktoria Plamenova, Snejina Mihailova, Elissaveta Naumova, and Anastasiya Petrova Mihaylova. "Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study." Turk J Haematol 2019.
Citação norma MLAVarbanova, Viktoria Plamenova, Snejina Mihailova, Elissaveta Naumova, and Anastasiya Petrova Mihaylova. "Certain Killer Immunoglobulin-Like Receptor (KIR)/KIR HLA Class I Ligand Genotypes Influence Natural Killer Antitumor Activity in Myelogenous Leukemia but Not in Acute Lymphoblastic Leukemia: A Case Control Leukemia Association Study." Turk J Haematol 2019.